GSK RSV vaccine secures age indication expansion from US FDA
(Alliance News) - GSK PLC on Friday said its respiratory syncytial virus vaccine, Arexvy, has gained an age indication expansion from the US Food & Drug Administration. Read More
| Price | 2,026.00p on 16-03-2026 at 19:00:06 |
|---|---|
| Change | -5.00p -0.25% |
| Buy | 2,028.00p |
| Sell | 2,027.00p |
| Last Trade: | Sell 2,391.00 at 2,026.00p |
| Day's Volume: | 6,815,220 |
| Last Close: | 2,026.00p |
| Open: | 2,037.00p |
| ISIN: | GB00BN7SWP63 |
| Day's Range | 2,026.00p - 2,053.00p |
| 52wk Range: | 1,242.50p - 2,282.00p |
| Market Capitalisation: | £81.17b |
| VWAP: | 2,034.15012p |
| Shares in Issue: | 4.01b |
Glaxosmithkline (GSK) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 2,391 | 2,026.00p | SI Trade Suspected SELL Trade |
17:45:35 - 16-Mar-26 |
| Sell* | 4,416 | 2,026.00p | SI Trade Suspected SELL Trade |
17:45:35 - 16-Mar-26 |
| Sell* | 4,072 | 2,026.00p | SI Trade Suspected SELL Trade |
17:45:35 - 16-Mar-26 |
| Sell* | 2,312 | 2,026.00p | SI Trade Suspected SELL Trade |
17:45:35 - 16-Mar-26 |
| Sell* | 170 | 2,026.00p | SI Trade Suspected SELL Trade |
17:45:35 - 16-Mar-26 |
| Sell* | 5,119 | 2,026.00p | SI Trade Suspected SELL Trade |
17:43:49 - 16-Mar-26 |
| Sell* | 22,892 | 2,026.00p | SI Trade Suspected SELL Trade |
17:43:49 - 16-Mar-26 |
| Sell* | 13,171 | 2,026.00p | SI Trade Suspected SELL Trade |
17:43:49 - 16-Mar-26 |
| Sell* | 2,408 | 2,026.00p | SI Trade Suspected SELL Trade |
17:43:48 - 16-Mar-26 |
| Sell* | 311 | 2,026.00p | SI Trade Suspected SELL Trade |
17:43:48 - 16-Mar-26 |
Glaxosmithkline (GSK) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 13th Mar 2026 10:31 am | RNS | US FDA approves Arexvy for adults 18-49 AIR |
| 13th Mar 2026 10:31 am | RNS | US FDA approves Arexvy for adults 18-49 AIR |
| 13th Mar 2026 7:00 am | RNS | Transaction in Own Shares |
| 13th Mar 2026 7:00 am | RNS | Transaction in Own Shares |
| 12th Mar 2026 7:00 am | RNS | Transaction in Own Shares |
| 11th Mar 2026 7:00 am | RNS | Transaction in Own Shares |
| 11th Mar 2026 7:00 am | RNS | Transaction in Own Shares |
| 10th Mar 2026 7:00 am | RNS | Transaction in Own Shares |
| 9th Mar 2026 3:00 pm | RNS | Board Committee Change |
| 9th Mar 2026 3:00 pm | RNS | Board Committee Change |